Annual CFO
-$2.24 M
+$3.64 M+61.88%
August 31, 2023
Summary
- As of February 10, 2025, NVOS annual cash flow from operations is -$2.24 million, with the most recent change of +$3.64 million (+61.88%) on August 31, 2023.
- During the last 3 years, NVOS annual CFO has fallen by -$1.80 million (-407.88%).
- NVOS annual CFO is now -2859.50% below its all-time high of -$75.80 thousand, reached on December 31, 2004.
Performance
NVOS Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$658.00 K
+$1.06 M+61.60%
May 31, 2024
Summary
- As of February 10, 2025, NVOS quarterly cash flow from operations is -$658.00 thousand, with the most recent change of +$1.06 million (+61.60%) on May 31, 2024.
- Over the past year, NVOS quarterly CFO has increased by +$199.70 thousand (+23.28%).
- NVOS quarterly CFO is now -197.37% below its all-time high of $675.80 thousand, reached on August 31, 2022.
Performance
NVOS Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$4.75 M
+$199.70 K+4.03%
May 31, 2024
Summary
- As of February 10, 2025, NVOS TTM cash flow from operations is -$4.75 million, with the most recent change of +$199.70 thousand (+4.03%) on May 31, 2024.
- Over the past year, NVOS TTM CFO has dropped by -$3.41 million (-255.03%).
- NVOS TTM CFO is now -23428.71% below its all-time high of -$20.20 thousand, reached on March 31, 2005.
Performance
NVOS TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
NVOS Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +61.9% | +23.3% | -255.0% |
| 3 y3 years | -407.9% | -136.5% | +12.0% |
| 5 y5 years | -140.1% | -136.5% | +12.0% |
NVOS Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -118.9% | +61.9% | -197.4% | +81.5% | -255.0% | +34.9% |
| 5 y | 5-year | -407.9% | +61.9% | -197.4% | +81.5% | -1527.7% | +34.9% |
| alltime | all time | -2859.5% | +61.9% | -197.4% | +81.5% | <-9999.0% | +34.9% |
Novo Integrated Sciences Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| May 2024 | - | -$658.00 K(-61.6%) | -$4.75 M(-4.0%) |
| Feb 2024 | - | -$1.71 M(-20.4%) | -$4.95 M(+20.3%) |
| Nov 2023 | - | -$2.15 M(+840.7%) | -$4.12 M(+83.5%) |
| Aug 2023 | -$2.24 M(-61.9%) | -$228.80 K(-73.3%) | -$2.24 M(+67.6%) |
| May 2023 | - | -$857.70 K(-2.4%) | -$1.34 M(-66.8%) |
| Feb 2023 | - | -$878.60 K(+215.8%) | -$4.03 M(-25.4%) |
| Nov 2022 | - | -$278.20 K(-141.2%) | -$5.40 M(-8.2%) |
| Aug 2022 | -$5.88 M(+474.2%) | $675.80 K(-119.0%) | -$5.88 M(-19.5%) |
| May 2022 | - | -$3.55 M(+57.7%) | -$7.31 M(+102.7%) |
| Feb 2022 | - | -$2.25 M(+196.5%) | -$3.60 M(+120.4%) |
| Nov 2021 | - | -$759.10 K(+1.8%) | -$1.64 M(+59.6%) |
| Aug 2021 | -$1.02 M(+132.0%) | -$745.50 K(-595.3%) | -$1.02 M(+247.5%) |
| May 2021 | - | $150.50 K(-153.4%) | -$294.90 K(+0.9%) |
| Feb 2021 | - | -$281.70 K(+90.2%) | -$292.30 K(+0.1%) |
| Nov 2020 | - | -$148.10 K(+849.4%) | -$292.00 K(-33.9%) |
| Aug 2020 | -$441.70 K(-46.3%) | -$15.60 K(-110.2%) | -$441.80 K(-38.4%) |
| May 2020 | - | $153.10 K(-154.4%) | -$717.50 K(-23.8%) |
| Feb 2020 | - | -$281.40 K(-5.5%) | -$942.00 K(-1.6%) |
| Nov 2019 | - | -$297.90 K(+2.3%) | -$957.20 K(+16.4%) |
| Aug 2019 | -$822.30 K(-12.0%) | -$291.30 K(+308.0%) | -$822.30 K(+31.5%) |
| May 2019 | - | -$71.40 K(-75.9%) | -$625.50 K(-32.0%) |
| Feb 2019 | - | -$296.60 K(+82.0%) | -$919.20 K(+23.3%) |
| Nov 2018 | - | -$163.00 K(+72.5%) | -$745.70 K(-20.2%) |
| Aug 2018 | -$934.50 K(+15.3%) | -$94.50 K(-74.1%) | -$934.50 K(+11.3%) |
| May 2018 | - | -$365.10 K(+196.6%) | -$840.00 K(+76.9%) |
| Feb 2018 | - | -$123.10 K(-65.0%) | -$474.90 K(+17.0%) |
| Nov 2017 | - | -$351.80 K(+551.5%) | -$405.80 K(+183.4%) |
| Aug 2017 | -$810.70 K(+638.3%) | - | - |
| Mar 2017 | - | -$54.00 K(+129.8%) | -$143.20 K(+30.4%) |
| Dec 2016 | -$109.80 K(-37.5%) | -$23.50 K(+19.3%) | -$109.80 K(+8.8%) |
| Sep 2016 | - | -$19.70 K(-57.2%) | -$100.90 K(-22.8%) |
| Jun 2016 | - | -$46.00 K(+123.3%) | -$130.70 K(-23.2%) |
| Mar 2016 | - | -$20.60 K(+41.1%) | -$170.10 K(-3.1%) |
| Dec 2015 | -$175.60 K(+21.1%) | -$14.60 K(-70.5%) | -$175.50 K(-12.8%) |
| Sep 2015 | - | -$49.50 K(-42.0%) | -$201.20 K(+10.2%) |
| Jun 2015 | - | -$85.40 K(+228.5%) | -$182.60 K(+41.6%) |
| Mar 2015 | - | -$26.00 K(-35.5%) | -$129.00 K(-11.0%) |
| Dec 2014 | -$145.00 K | -$40.30 K(+30.4%) | -$145.00 K(0.0%) |
| Sep 2014 | - | -$30.90 K(-2.8%) | -$145.00 K(-21.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2014 | - | -$31.80 K(-24.3%) | -$184.40 K(-23.8%) |
| Mar 2014 | - | -$42.00 K(+4.2%) | -$242.10 K(-2.9%) |
| Dec 2013 | -$249.30 K(-28.8%) | -$40.30 K(-42.7%) | -$249.40 K(-1.8%) |
| Sep 2013 | - | -$70.30 K(-21.5%) | -$254.00 K(+5.9%) |
| Jun 2013 | - | -$89.50 K(+81.5%) | -$239.80 K(-5.9%) |
| Mar 2013 | - | -$49.30 K(+9.8%) | -$254.90 K(-27.2%) |
| Dec 2012 | -$350.10 K(-22.5%) | -$44.90 K(-20.0%) | -$350.10 K(-10.9%) |
| Sep 2012 | - | -$56.10 K(-46.4%) | -$393.00 K(+5.6%) |
| Jun 2012 | - | -$104.60 K(-27.6%) | -$372.30 K(-8.3%) |
| Mar 2012 | - | -$144.50 K(+64.6%) | -$405.80 K(-10.2%) |
| Dec 2011 | -$451.80 K(-70.9%) | -$87.80 K(+148.0%) | -$451.80 K(-10.4%) |
| Sep 2011 | - | -$35.40 K(-74.4%) | -$504.30 K(-32.8%) |
| Jun 2011 | - | -$138.10 K(-27.5%) | -$750.20 K(-41.0%) |
| Mar 2011 | - | -$190.50 K(+35.8%) | -$1.27 M(-18.2%) |
| Dec 2010 | -$1.55 M(+63.3%) | -$140.30 K(-50.1%) | -$1.55 M(-12.1%) |
| Sep 2010 | - | -$281.30 K(-57.3%) | -$1.77 M(+1.8%) |
| Jun 2010 | - | -$659.40 K(+39.3%) | -$1.74 M(+45.1%) |
| Mar 2010 | - | -$473.40 K(+33.6%) | -$1.20 M(+25.8%) |
| Dec 2009 | -$951.80 K(+209.4%) | -$354.40 K(+41.5%) | -$951.80 K(+44.7%) |
| Sep 2009 | - | -$250.40 K(+110.1%) | -$657.70 K(+30.2%) |
| Jun 2009 | - | -$119.20 K(-47.7%) | -$505.10 K(+0.4%) |
| Mar 2009 | - | -$227.80 K(+277.8%) | -$503.00 K(+63.5%) |
| Dec 2008 | -$307.60 K(-36.8%) | -$60.30 K(-38.3%) | -$307.60 K(-25.5%) |
| Sep 2008 | - | -$97.80 K(-16.5%) | -$413.00 K(-0.6%) |
| Jun 2008 | - | -$117.10 K(+261.4%) | -$415.30 K(+11.0%) |
| Mar 2008 | - | -$32.40 K(-80.4%) | -$374.10 K(-23.2%) |
| Dec 2007 | -$486.90 K(+6.8%) | -$165.70 K(+65.5%) | -$486.80 K(+26.0%) |
| Sep 2007 | - | -$100.10 K(+31.9%) | -$386.40 K(-6.7%) |
| Jun 2007 | - | -$75.90 K(-47.7%) | -$414.20 K(-22.1%) |
| Mar 2007 | - | -$145.10 K(+122.2%) | -$531.50 K(+16.6%) |
| Dec 2006 | -$455.70 K(+268.1%) | -$65.30 K(-48.9%) | -$455.70 K(+9.4%) |
| Sep 2006 | - | -$127.90 K(-33.8%) | -$416.50 K(+34.5%) |
| Jun 2006 | - | -$193.20 K(+178.8%) | -$309.70 K(+79.1%) |
| Mar 2006 | - | -$69.30 K(+165.5%) | -$172.90 K(+39.7%) |
| Dec 2005 | -$123.80 K(+63.3%) | -$26.10 K(+23.7%) | -$123.80 K(+26.7%) |
| Sep 2005 | - | -$21.10 K(-62.6%) | -$97.70 K(+27.5%) |
| Jun 2005 | - | -$56.40 K(+179.2%) | -$76.60 K(+279.2%) |
| Mar 2005 | - | -$20.20 K | -$20.20 K |
| Dec 2004 | -$75.80 K | - | - |
FAQ
- What is Novo Integrated Sciences annual cash flow from operations?
- What is the all time high annual CFO for Novo Integrated Sciences?
- What is Novo Integrated Sciences annual CFO year-on-year change?
- What is Novo Integrated Sciences quarterly cash flow from operations?
- What is the all time high quarterly CFO for Novo Integrated Sciences?
- What is Novo Integrated Sciences quarterly CFO year-on-year change?
- What is Novo Integrated Sciences TTM cash flow from operations?
- What is the all time high TTM CFO for Novo Integrated Sciences?
- What is Novo Integrated Sciences TTM CFO year-on-year change?
What is Novo Integrated Sciences annual cash flow from operations?
The current annual CFO of NVOS is -$2.24 M
What is the all time high annual CFO for Novo Integrated Sciences?
Novo Integrated Sciences all-time high annual cash flow from operations is -$75.80 K
What is Novo Integrated Sciences annual CFO year-on-year change?
Over the past year, NVOS annual cash flow from operations has changed by +$3.64 M (+61.88%)
What is Novo Integrated Sciences quarterly cash flow from operations?
The current quarterly CFO of NVOS is -$658.00 K
What is the all time high quarterly CFO for Novo Integrated Sciences?
Novo Integrated Sciences all-time high quarterly cash flow from operations is $675.80 K
What is Novo Integrated Sciences quarterly CFO year-on-year change?
Over the past year, NVOS quarterly cash flow from operations has changed by +$199.70 K (+23.28%)
What is Novo Integrated Sciences TTM cash flow from operations?
The current TTM CFO of NVOS is -$4.75 M
What is the all time high TTM CFO for Novo Integrated Sciences?
Novo Integrated Sciences all-time high TTM cash flow from operations is -$20.20 K
What is Novo Integrated Sciences TTM CFO year-on-year change?
Over the past year, NVOS TTM cash flow from operations has changed by -$3.41 M (-255.03%)